Activist 13D/13G Filings - AIM ImmunoTech Inc. (AIM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-01-03
4:24 pm
Unchanged		13DAIM IMMUNOTECH INC
AIM		Deutsch Todd1,716,100
3.5%		0
(Unchanged)		View
2023-08-28
06:36 am
Unchanged		13DAIM IMMUNOTECH INC
AIM		Deutsch Todd1,716,100
3.5%		0
(Unchanged)		View
2023-08-07
4:15 pm
Unchanged		13DAIM IMMUNOTECH INC
AIM		Deutsch Todd1,716,100
3.5%		0
(Unchanged)		View
2023-07-27
5:01 pm
Purchase		13DAIM IMMUNOTECH INC
AIM		Deutsch Todd1,716,100
3.5%		1,716,100increase
(New Position)		View
2021-02-08
4:43 pm
Sale		13GAIM IMMUNOTECH INC
AIM		Hudson Bay Capital Management LP7,747
0.02%		-909,451decrease
(-99.16%)		View
2020-02-14
4:31 pm
Sale		13GAIM IMMUNOTECH INC
AIM		Anson Funds Management LP434,030
4.9%		-843,192decrease
(-66.02%)		View
2020-01-31
1:45 pm
Purchase		13GAIM IMMUNOTECH INC
AIM		Hudson Bay Capital Management LP917,198
9.99%		917,198increase
(New Position)		View
2019-09-30
06:14 am
Purchase		13GAIM IMMUNOTECH INC
AIM		Anson Funds Management LP1,277,222
9.9%		1,277,222increase
(New Position)		View
2019-06-28
4:05 pm
Sale		13DHEMISPHERX BIOPHARMA INC P
HEB		Equels Thomas K120,498
5.3%		-3,758,416decrease
(-96.89%)		View
2019-06-18
4:04 pm
Purchase		13DHEMISPHERX BIOPHARMA INC P
HEB		Equels Thomas K3,878,914
4.2%		3,878,914increase
(New Position)		View